CCR4 and neoplasm: Six weeks after tumor implantation, there was a significantly decreased tumor volume (219.7 ± 99.1 mm3) in mice receiving prophylactic CCR4 inhibition compared to vehicle controls (556.4 ± 351.8 mm3) (p = 0.026).